Vedanta Biosciences
Phase 2Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria.
Founded
2010
Focus
BiologicsMicrobiome
About
Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria.
Funding History
3Total raised: $183.6M
Series D$106.5MMagnetar CapitalMay 15, 2022
Series C$27.1MRock Springs CapitalJun 15, 2019
Series B$50MSeventure PartnersDec 15, 2016
Company Info
TypePrivate
Founded2010
LocationCambridge, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile